Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

SELL
$13.63 - $33.98 $2,371 - $5,912
-174 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$16.12 - $24.98 $2,804 - $4,346
174 New
174 $4,000
Q3 2019

Nov 04, 2019

SELL
$15.49 - $25.78 $2,369 - $3,944
-153 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$23.0 - $32.19 $3,519 - $4,925
153 New
153 $4,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.7B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.